| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogen Sulfide | 21 | 2024 | 141 | 7.360 |
Why?
|
| Nitric Oxide | 58 | 2024 | 2136 | 5.610 |
Why?
|
| Heart Arrest | 19 | 2024 | 1514 | 3.860 |
Why?
|
| Quinone Reductases | 4 | 2024 | 23 | 2.040 |
Why?
|
| Cardiopulmonary Resuscitation | 11 | 2022 | 993 | 1.960 |
Why?
|
| Spinal Cord Ischemia | 3 | 2023 | 94 | 1.700 |
Why?
|
| Sulfides | 9 | 2024 | 169 | 1.690 |
Why?
|
| Administration, Inhalation | 35 | 2023 | 1157 | 1.680 |
Why?
|
| Nitric Oxide Synthase Type III | 14 | 2011 | 705 | 1.570 |
Why?
|
| Leigh Disease | 5 | 2024 | 89 | 1.550 |
Why?
|
| Vasoconstriction | 15 | 2019 | 592 | 1.490 |
Why?
|
| Pulmonary Circulation | 16 | 2019 | 737 | 1.430 |
Why?
|
| Guanylate Cyclase | 10 | 2022 | 205 | 1.400 |
Why?
|
| Nitric Oxide Synthase Type II | 17 | 2018 | 517 | 1.370 |
Why?
|
| Endotoxemia | 7 | 2019 | 196 | 1.280 |
Why?
|
| Vascular Resistance | 11 | 2019 | 930 | 1.230 |
Why?
|
| Paraplegia | 3 | 2023 | 161 | 1.160 |
Why?
|
| Thiosulfates | 3 | 2015 | 53 | 1.090 |
Why?
|
| Vasodilator Agents | 9 | 2017 | 973 | 1.060 |
Why?
|
| Mice, Inbred C57BL | 52 | 2024 | 22174 | 1.000 |
Why?
|
| Myocytes, Cardiac | 13 | 2015 | 1668 | 0.960 |
Why?
|
| Galactosamine | 2 | 2014 | 26 | 0.940 |
Why?
|
| Nitric Oxide Synthase | 12 | 2013 | 908 | 0.940 |
Why?
|
| Aldehyde Oxidoreductases | 3 | 2019 | 88 | 0.920 |
Why?
|
| Hibernation | 1 | 2024 | 47 | 0.900 |
Why?
|
| Vasodilation | 11 | 2007 | 962 | 0.900 |
Why?
|
| Mice | 91 | 2024 | 81539 | 0.890 |
Why?
|
| Hypothermia, Induced | 2 | 2022 | 753 | 0.890 |
Why?
|
| Shock, Septic | 6 | 2014 | 768 | 0.870 |
Why?
|
| Myocardial Contraction | 11 | 2013 | 1515 | 0.860 |
Why?
|
| Caspase 3 | 7 | 2015 | 731 | 0.840 |
Why?
|
| Mitochondria | 9 | 2024 | 3624 | 0.820 |
Why?
|
| Reperfusion Injury | 4 | 2018 | 1023 | 0.810 |
Why?
|
| Lipopolysaccharides | 8 | 2017 | 2206 | 0.800 |
Why?
|
| Liver Failure, Acute | 2 | 2014 | 181 | 0.800 |
Why?
|
| Brain Injuries | 4 | 2023 | 2054 | 0.800 |
Why?
|
| Neuroprotective Agents | 3 | 2018 | 957 | 0.800 |
Why?
|
| Animals | 119 | 2024 | 168475 | 0.780 |
Why?
|
| Dexmedetomidine | 2 | 2023 | 319 | 0.760 |
Why?
|
| Hyperemia | 1 | 2022 | 221 | 0.760 |
Why?
|
| Lung | 25 | 2023 | 10002 | 0.750 |
Why?
|
| Hypothermia | 1 | 2022 | 188 | 0.740 |
Why?
|
| Propofol | 3 | 2023 | 603 | 0.720 |
Why?
|
| Hypertension, Pulmonary | 16 | 2018 | 1578 | 0.710 |
Why?
|
| Nitric Oxide Donors | 1 | 2020 | 126 | 0.690 |
Why?
|
| Cardiopulmonary Bypass | 6 | 2024 | 1092 | 0.680 |
Why?
|
| Brain Ischemia | 4 | 2015 | 3049 | 0.670 |
Why?
|
| Heart | 7 | 2019 | 4404 | 0.670 |
Why?
|
| Arginase | 1 | 2019 | 80 | 0.640 |
Why?
|
| Free Radical Scavengers | 3 | 2019 | 211 | 0.630 |
Why?
|
| Phosphodiesterase Inhibitors | 4 | 2005 | 214 | 0.600 |
Why?
|
| Farnesyltranstransferase | 2 | 2014 | 71 | 0.580 |
Why?
|
| Mice, Knockout | 21 | 2022 | 14417 | 0.570 |
Why?
|
| Benzoates | 1 | 2019 | 212 | 0.570 |
Why?
|
| Pulmonary Artery | 13 | 2024 | 1927 | 0.570 |
Why?
|
| Oxidoreductases | 1 | 2019 | 413 | 0.560 |
Why?
|
| Enzyme Inhibitors | 10 | 2019 | 3713 | 0.560 |
Why?
|
| Acute Lung Injury | 3 | 2022 | 367 | 0.560 |
Why?
|
| Endotoxins | 8 | 2012 | 520 | 0.550 |
Why?
|
| Pyrimidinones | 1 | 2019 | 385 | 0.530 |
Why?
|
| Myocardial Reperfusion Injury | 5 | 2011 | 481 | 0.530 |
Why?
|
| Cystathionine gamma-Lyase | 2 | 2013 | 36 | 0.530 |
Why?
|
| Sulfites | 1 | 2015 | 83 | 0.510 |
Why?
|
| Oxygen | 16 | 2024 | 4227 | 0.500 |
Why?
|
| Anesthetics, Inhalation | 11 | 2017 | 574 | 0.500 |
Why?
|
| Apoptosis | 14 | 2018 | 9490 | 0.500 |
Why?
|
| Isoflurane | 6 | 2023 | 384 | 0.490 |
Why?
|
| Cyclic GMP | 9 | 2011 | 395 | 0.490 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2015 | 242 | 0.470 |
Why?
|
| Calcium | 11 | 2015 | 5722 | 0.470 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 5 | 2011 | 858 | 0.460 |
Why?
|
| Protective Agents | 1 | 2015 | 150 | 0.460 |
Why?
|
| Cardiovascular Agents | 1 | 2020 | 840 | 0.450 |
Why?
|
| Methyl Ethers | 7 | 2017 | 196 | 0.440 |
Why?
|
| Glutathione Reductase | 1 | 2013 | 25 | 0.430 |
Why?
|
| Parkinson Disease | 4 | 2022 | 2877 | 0.430 |
Why?
|
| Ventilation-Perfusion Ratio | 2 | 2011 | 117 | 0.430 |
Why?
|
| Disease Models, Animal | 20 | 2023 | 18255 | 0.410 |
Why?
|
| Respiratory Insufficiency | 5 | 2023 | 1230 | 0.400 |
Why?
|
| Myocardium | 10 | 2015 | 4725 | 0.400 |
Why?
|
| Electron Transport Complex I | 3 | 2021 | 153 | 0.400 |
Why?
|
| Inflammation | 7 | 2024 | 10774 | 0.390 |
Why?
|
| Quinolones | 1 | 2014 | 378 | 0.370 |
Why?
|
| Carbon Monoxide Poisoning | 2 | 2023 | 65 | 0.370 |
Why?
|
| Sciatic Nerve | 1 | 2014 | 617 | 0.370 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2011 | 69 | 0.370 |
Why?
|
| Reactive Oxygen Species | 11 | 2024 | 2139 | 0.370 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2019 | 3627 | 0.360 |
Why?
|
| Ventricular Dysfunction, Left | 9 | 2009 | 2118 | 0.350 |
Why?
|
| Pulmonary Ventilation | 3 | 2011 | 372 | 0.350 |
Why?
|
| Neurons | 5 | 2018 | 9463 | 0.330 |
Why?
|
| Neurodegenerative Diseases | 3 | 2023 | 1088 | 0.330 |
Why?
|
| Cardiomyopathies | 3 | 2013 | 1964 | 0.330 |
Why?
|
| Brain | 11 | 2024 | 27121 | 0.330 |
Why?
|
| Male | 80 | 2024 | 360846 | 0.320 |
Why?
|
| Calcium-Binding Proteins | 4 | 2021 | 1069 | 0.320 |
Why?
|
| NAD | 3 | 2021 | 614 | 0.310 |
Why?
|
| Hemolysis | 2 | 2024 | 415 | 0.310 |
Why?
|
| Pneumonia, Viral | 3 | 2021 | 3206 | 0.310 |
Why?
|
| Cause of Death | 1 | 2019 | 3683 | 0.310 |
Why?
|
| Antioxidants | 2 | 2014 | 1668 | 0.300 |
Why?
|
| Cardiotonic Agents | 3 | 2009 | 539 | 0.300 |
Why?
|
| Analgesics | 1 | 2014 | 1070 | 0.290 |
Why?
|
| Cytokines | 10 | 2024 | 7396 | 0.290 |
Why?
|
| Ventricular Function, Right | 4 | 2024 | 617 | 0.290 |
Why?
|
| Critical Care | 1 | 2020 | 2697 | 0.290 |
Why?
|
| Sarcoplasmic Reticulum | 4 | 2010 | 163 | 0.290 |
Why?
|
| Respiration | 6 | 2024 | 1656 | 0.280 |
Why?
|
| Movement Disorders | 1 | 2011 | 459 | 0.280 |
Why?
|
| Purinones | 2 | 1998 | 13 | 0.280 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2012 | 895 | 0.280 |
Why?
|
| Resuscitation | 3 | 2024 | 673 | 0.280 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2021 | 295 | 0.270 |
Why?
|
| Sheep | 9 | 2011 | 1440 | 0.260 |
Why?
|
| Motor Neurons | 1 | 2011 | 870 | 0.260 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3086 | 0.260 |
Why?
|
| Oxidation-Reduction | 3 | 2019 | 2231 | 0.260 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2014 | 1555 | 0.260 |
Why?
|
| Transcription Factor RelA | 2 | 2018 | 254 | 0.260 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2012 | 1809 | 0.250 |
Why?
|
| Ischemia | 2 | 2012 | 1884 | 0.250 |
Why?
|
| Friedreich Ataxia | 2 | 2023 | 77 | 0.250 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2007 | 851 | 0.240 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2010 | 621 | 0.240 |
Why?
|
| Sulfur | 2 | 2023 | 162 | 0.240 |
Why?
|
| Cytosol | 4 | 2008 | 888 | 0.240 |
Why?
|
| Arachidonate 5-Lipoxygenase | 2 | 2005 | 128 | 0.240 |
Why?
|
| Blood Substitutes | 2 | 2019 | 57 | 0.230 |
Why?
|
| Leukotrienes | 4 | 2011 | 231 | 0.230 |
Why?
|
| Sciuridae | 1 | 2024 | 78 | 0.230 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2022 | 4352 | 0.220 |
Why?
|
| Cardiovascular System | 2 | 2023 | 834 | 0.220 |
Why?
|
| Hemodynamics | 16 | 2016 | 4160 | 0.220 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2023 | 8181 | 0.220 |
Why?
|
| Respiratory Therapy | 2 | 2023 | 125 | 0.220 |
Why?
|
| Xenon | 6 | 2004 | 112 | 0.220 |
Why?
|
| Glutathione Disulfide | 1 | 2023 | 33 | 0.220 |
Why?
|
| Cytoprotection | 2 | 2015 | 200 | 0.210 |
Why?
|
| Sepsis | 7 | 2014 | 2585 | 0.210 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2023 | 117 | 0.210 |
Why?
|
| Metronidazole | 1 | 2024 | 232 | 0.210 |
Why?
|
| Polycythemia | 1 | 2023 | 124 | 0.200 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2017 | 579 | 0.200 |
Why?
|
| Cells, Cultured | 8 | 2021 | 18966 | 0.200 |
Why?
|
| Receptors, Leukotriene | 2 | 2011 | 95 | 0.200 |
Why?
|
| Mice, Mutant Strains | 7 | 2021 | 1749 | 0.200 |
Why?
|
| Cardiac Output | 2 | 2018 | 831 | 0.200 |
Why?
|
| Bacterial Infections | 1 | 2010 | 1391 | 0.200 |
Why?
|
| Gases | 2 | 2023 | 204 | 0.190 |
Why?
|
| Phospholipases A | 1 | 2002 | 204 | 0.190 |
Why?
|
| Azides | 1 | 2021 | 118 | 0.190 |
Why?
|
| Cell Survival | 5 | 2019 | 5791 | 0.190 |
Why?
|
| Cell Hypoxia | 3 | 2021 | 657 | 0.190 |
Why?
|
| Natural Killer T-Cells | 1 | 2024 | 322 | 0.190 |
Why?
|
| Administration, Intranasal | 1 | 2023 | 477 | 0.190 |
Why?
|
| Humans | 71 | 2024 | 761596 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2021 | 10766 | 0.180 |
Why?
|
| Antidotes | 1 | 2021 | 138 | 0.180 |
Why?
|
| Selenium | 1 | 2024 | 417 | 0.180 |
Why?
|
| Survival Rate | 6 | 2016 | 12723 | 0.180 |
Why?
|
| Phosphorylation | 4 | 2015 | 8321 | 0.180 |
Why?
|
| Blood Pressure | 12 | 2021 | 8481 | 0.180 |
Why?
|
| Nitrogen Dioxide | 1 | 2023 | 522 | 0.180 |
Why?
|
| Carbon Monoxide | 3 | 2019 | 547 | 0.170 |
Why?
|
| Mice, Inbred DBA | 1 | 2021 | 621 | 0.170 |
Why?
|
| Bronchodilator Agents | 1 | 2004 | 512 | 0.170 |
Why?
|
| Neuroendocrine Cells | 1 | 2021 | 62 | 0.170 |
Why?
|
| Diffusion | 2 | 2012 | 814 | 0.170 |
Why?
|
| Patient Isolation | 1 | 2020 | 100 | 0.170 |
Why?
|
| Memantine | 2 | 2012 | 108 | 0.170 |
Why?
|
| Catalase | 1 | 2020 | 218 | 0.170 |
Why?
|
| Treatment Outcome | 12 | 2020 | 64685 | 0.160 |
Why?
|
| Iron-Binding Proteins | 1 | 2019 | 79 | 0.160 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2019 | 83 | 0.160 |
Why?
|
| Klebsiella pneumoniae | 1 | 2020 | 250 | 0.160 |
Why?
|
| Interleukin-6 | 4 | 2022 | 3208 | 0.160 |
Why?
|
| Mitochondria, Heart | 2 | 2010 | 229 | 0.160 |
Why?
|
| Mixed Function Oxygenases | 1 | 2020 | 265 | 0.160 |
Why?
|
| Mice, Transgenic | 6 | 2018 | 9542 | 0.160 |
Why?
|
| Heart Rate | 5 | 2024 | 4195 | 0.150 |
Why?
|
| Nitroglycerin | 2 | 1996 | 329 | 0.150 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1999 | 284 | 0.150 |
Why?
|
| Oxyhemoglobins | 1 | 2019 | 211 | 0.150 |
Why?
|
| Oxidative Stress | 7 | 2024 | 3113 | 0.150 |
Why?
|
| Peritonitis | 2 | 2010 | 368 | 0.150 |
Why?
|
| Nitrites | 2 | 2011 | 159 | 0.150 |
Why?
|
| Rats | 10 | 2023 | 23741 | 0.150 |
Why?
|
| Cell Line, Tumor | 6 | 2019 | 16990 | 0.150 |
Why?
|
| Iron-Dextran Complex | 1 | 2017 | 13 | 0.150 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.140 |
Why?
|
| Behavior, Animal | 3 | 2014 | 1878 | 0.140 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2021 | 829 | 0.140 |
Why?
|
| Hypotension | 1 | 2003 | 879 | 0.140 |
Why?
|
| Hyperoxia | 1 | 2019 | 258 | 0.140 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2018 | 139 | 0.140 |
Why?
|
| Nervous System | 2 | 2011 | 545 | 0.140 |
Why?
|
| bcl-X Protein | 1 | 2018 | 410 | 0.140 |
Why?
|
| Hepatocytes | 2 | 2014 | 1233 | 0.140 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2010 | 347 | 0.140 |
Why?
|
| Cecum | 2 | 2014 | 233 | 0.140 |
Why?
|
| Heart Diseases | 6 | 2011 | 2781 | 0.130 |
Why?
|
| Indazoles | 1 | 1998 | 304 | 0.130 |
Why?
|
| Phototherapy | 1 | 2019 | 368 | 0.130 |
Why?
|
| Virulence | 1 | 2020 | 1303 | 0.130 |
Why?
|
| Female | 43 | 2024 | 392705 | 0.130 |
Why?
|
| Solubility | 4 | 2016 | 1091 | 0.130 |
Why?
|
| Protein Engineering | 1 | 2020 | 549 | 0.130 |
Why?
|
| Epoxide Hydrolases | 1 | 2016 | 122 | 0.130 |
Why?
|
| Coronary Artery Bypass | 3 | 2011 | 2188 | 0.130 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2016 | 63 | 0.130 |
Why?
|
| Receptors, Cell Surface | 2 | 2022 | 2822 | 0.130 |
Why?
|
| Organoselenium Compounds | 1 | 2015 | 21 | 0.120 |
Why?
|
| Platelet Activation | 1 | 1999 | 645 | 0.120 |
Why?
|
| Electroencephalography | 2 | 2022 | 6237 | 0.120 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2021 | 628 | 0.120 |
Why?
|
| Isoproterenol | 1 | 2015 | 395 | 0.120 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2019 | 373 | 0.120 |
Why?
|
| Endothelium, Vascular | 2 | 2019 | 4431 | 0.120 |
Why?
|
| Kidney | 1 | 2010 | 7048 | 0.120 |
Why?
|
| Anion Transport Proteins | 1 | 2015 | 141 | 0.120 |
Why?
|
| Thiamine | 1 | 2016 | 160 | 0.120 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2015 | 128 | 0.120 |
Why?
|
| Bacterial Load | 2 | 2014 | 152 | 0.120 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1995 | 149 | 0.120 |
Why?
|
| Trachea | 1 | 2021 | 1089 | 0.120 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2019 | 1462 | 0.120 |
Why?
|
| Lactic Acid | 1 | 2020 | 1139 | 0.120 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 2 | 2011 | 89 | 0.120 |
Why?
|
| Gene Expression Regulation | 4 | 2018 | 11904 | 0.110 |
Why?
|
| Liver Transplantation | 2 | 2018 | 2330 | 0.110 |
Why?
|
| Ventilators, Mechanical | 2 | 2007 | 288 | 0.110 |
Why?
|
| Signal Transduction | 6 | 2018 | 23447 | 0.110 |
Why?
|
| Lung Diseases | 1 | 2004 | 1909 | 0.110 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 496 | 0.110 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2015 | 345 | 0.110 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2005 | 201 | 0.110 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2022 | 1159 | 0.110 |
Why?
|
| Hemoglobins | 3 | 2023 | 1526 | 0.110 |
Why?
|
| NG-Nitroarginine Methyl Ester | 4 | 2007 | 260 | 0.110 |
Why?
|
| Occupational Health | 1 | 2020 | 806 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2024 | 5247 | 0.110 |
Why?
|
| Isoenzymes | 3 | 2011 | 1687 | 0.110 |
Why?
|
| Hypertrophy | 1 | 2015 | 561 | 0.110 |
Why?
|
| Electric Impedance | 1 | 2018 | 757 | 0.110 |
Why?
|
| Monitoring, Intraoperative | 3 | 2018 | 942 | 0.110 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 246 | 0.110 |
Why?
|
| Aerosols | 4 | 2018 | 635 | 0.110 |
Why?
|
| Respiratory Mechanics | 3 | 2011 | 699 | 0.110 |
Why?
|
| Nitrogen | 1 | 2014 | 348 | 0.110 |
Why?
|
| Glutathione | 2 | 2012 | 583 | 0.100 |
Why?
|
| Symporters | 1 | 2015 | 363 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 2457 | 0.100 |
Why?
|
| Enzyme Activation | 4 | 2011 | 3597 | 0.100 |
Why?
|
| Carbon | 1 | 2016 | 666 | 0.100 |
Why?
|
| Anemia | 2 | 2019 | 1509 | 0.100 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2013 | 111 | 0.100 |
Why?
|
| Macrophages, Peritoneal | 1 | 2013 | 238 | 0.100 |
Why?
|
| RNA Interference | 1 | 2021 | 2832 | 0.100 |
Why?
|
| Inflammation Mediators | 2 | 2011 | 1886 | 0.100 |
Why?
|
| Glucose | 2 | 2015 | 4347 | 0.100 |
Why?
|
| Immunoblotting | 1 | 2015 | 1646 | 0.100 |
Why?
|
| Bone Marrow | 1 | 2022 | 2911 | 0.100 |
Why?
|
| Systole | 2 | 2024 | 936 | 0.100 |
Why?
|
| Water | 2 | 2023 | 1411 | 0.100 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2013 | 441 | 0.100 |
Why?
|
| Oxygenators, Membrane | 2 | 2023 | 56 | 0.100 |
Why?
|
| Arginine | 1 | 1995 | 934 | 0.100 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2013 | 426 | 0.100 |
Why?
|
| Brain Chemistry | 1 | 2015 | 960 | 0.100 |
Why?
|
| Sarcoma | 1 | 2022 | 1801 | 0.090 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 4 | 2004 | 65 | 0.090 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2011 | 65 | 0.090 |
Why?
|
| Lymphocytes | 1 | 2019 | 2612 | 0.090 |
Why?
|
| Anesthesia Recovery Period | 4 | 2000 | 155 | 0.090 |
Why?
|
| Air | 1 | 2011 | 187 | 0.090 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2011 | 88 | 0.090 |
Why?
|
| Troponin I | 1 | 2015 | 651 | 0.090 |
Why?
|
| Cerebellum | 1 | 1998 | 1501 | 0.090 |
Why?
|
| Deoxyglucose | 1 | 2011 | 333 | 0.090 |
Why?
|
| Time Factors | 9 | 2015 | 39969 | 0.090 |
Why?
|
| Thiophenes | 1 | 2015 | 569 | 0.090 |
Why?
|
| Liver | 3 | 2014 | 7528 | 0.090 |
Why?
|
| Exhalation | 1 | 2011 | 181 | 0.090 |
Why?
|
| Anesthesia | 3 | 1998 | 1595 | 0.090 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2010 | 122 | 0.090 |
Why?
|
| Amphetamine | 1 | 2011 | 224 | 0.090 |
Why?
|
| Piperazines | 1 | 2001 | 2523 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2011 | 1492 | 0.090 |
Why?
|
| KATP Channels | 1 | 2010 | 48 | 0.090 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2011 | 120 | 0.090 |
Why?
|
| Body Temperature | 2 | 2011 | 781 | 0.090 |
Why?
|
| Hyperalgesia | 1 | 2014 | 532 | 0.090 |
Why?
|
| Doxorubicin | 3 | 2022 | 2224 | 0.090 |
Why?
|
| Models, Chemical | 1 | 2012 | 611 | 0.090 |
Why?
|
| Nitrates | 1 | 2011 | 263 | 0.090 |
Why?
|
| Echocardiography, Doppler | 3 | 2006 | 897 | 0.090 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2012 | 448 | 0.090 |
Why?
|
| Oxygen Consumption | 3 | 2011 | 1866 | 0.090 |
Why?
|
| Occupational Exposure | 1 | 2020 | 1813 | 0.080 |
Why?
|
| Methamphetamine | 1 | 2011 | 165 | 0.080 |
Why?
|
| Leukocyte Count | 3 | 2019 | 1596 | 0.080 |
Why?
|
| Massachusetts | 2 | 2020 | 8833 | 0.080 |
Why?
|
| Pulmonary Gas Exchange | 3 | 2011 | 379 | 0.080 |
Why?
|
| Drug Synergism | 2 | 2005 | 1757 | 0.080 |
Why?
|
| Organ Size | 4 | 2011 | 2254 | 0.080 |
Why?
|
| NF-kappa B | 2 | 2014 | 2490 | 0.080 |
Why?
|
| Peroxidase | 4 | 2011 | 609 | 0.080 |
Why?
|
| Nucleus Accumbens | 1 | 2011 | 366 | 0.080 |
Why?
|
| Echocardiography | 6 | 2009 | 4989 | 0.080 |
Why?
|
| Methionine | 1 | 2011 | 572 | 0.080 |
Why?
|
| Pneumonia | 1 | 2020 | 2143 | 0.080 |
Why?
|
| Platelet Adhesiveness | 2 | 1999 | 154 | 0.080 |
Why?
|
| Bronchi | 3 | 2018 | 845 | 0.080 |
Why?
|
| Ventricular Remodeling | 2 | 2007 | 1267 | 0.080 |
Why?
|
| Bacteria | 1 | 2020 | 2199 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 2151 | 0.080 |
Why?
|
| Carbon Dioxide | 2 | 2011 | 1147 | 0.080 |
Why?
|
| Pain Measurement | 1 | 1999 | 3551 | 0.080 |
Why?
|
| Intestinal Perforation | 1 | 2010 | 249 | 0.080 |
Why?
|
| Anesthesia, General | 3 | 2023 | 1174 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2019 | 3492 | 0.080 |
Why?
|
| Blood Platelets | 1 | 1999 | 2479 | 0.080 |
Why?
|
| Blotting, Western | 3 | 2011 | 5035 | 0.070 |
Why?
|
| Mutation | 3 | 2024 | 30053 | 0.070 |
Why?
|
| Postoperative Complications | 3 | 2019 | 15633 | 0.070 |
Why?
|
| Nitrous Oxide | 3 | 2004 | 166 | 0.070 |
Why?
|
| Stem Cells | 1 | 2021 | 3524 | 0.070 |
Why?
|
| Bronchoconstriction | 2 | 2007 | 142 | 0.070 |
Why?
|
| K562 Cells | 2 | 2020 | 642 | 0.070 |
Why?
|
| Inhalation | 1 | 2008 | 143 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2020 | 3060 | 0.070 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2010 | 662 | 0.070 |
Why?
|
| Homeostasis | 2 | 2017 | 3323 | 0.070 |
Why?
|
| Oropharynx | 2 | 1998 | 138 | 0.070 |
Why?
|
| Blood Gas Analysis | 3 | 2016 | 379 | 0.070 |
Why?
|
| Hypertension | 4 | 2008 | 8540 | 0.070 |
Why?
|
| Drug Design | 1 | 2012 | 1048 | 0.070 |
Why?
|
| Anesthetics, Combined | 2 | 2004 | 43 | 0.070 |
Why?
|
| Acute Kidney Injury | 1 | 2019 | 1924 | 0.070 |
Why?
|
| Cell Death | 1 | 2012 | 1679 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1903 | 0.070 |
Why?
|
| Serotonin | 1 | 2011 | 1041 | 0.070 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2011 | 774 | 0.070 |
Why?
|
| Vascular Diseases | 1 | 2015 | 1161 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 1406 | 0.070 |
Why?
|
| Xanthine Oxidase | 1 | 2006 | 69 | 0.070 |
Why?
|
| DNA Primers | 1 | 2011 | 2820 | 0.070 |
Why?
|
| Gestational Age | 1 | 2015 | 3577 | 0.070 |
Why?
|
| Heart-Assist Devices | 2 | 2015 | 1287 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 2226 | 0.070 |
Why?
|
| Spinal Cord | 1 | 2014 | 1819 | 0.070 |
Why?
|
| Heart Defects, Congenital | 2 | 2004 | 4671 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2011 | 3204 | 0.070 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 1 | 1 | 2005 | 6 | 0.070 |
Why?
|
| Myocardial Reperfusion | 1 | 2007 | 338 | 0.070 |
Why?
|
| Cysteine | 1 | 2011 | 891 | 0.070 |
Why?
|
| Analysis of Variance | 4 | 2011 | 6228 | 0.070 |
Why?
|
| Acute Disease | 4 | 2007 | 7237 | 0.060 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 598 | 0.060 |
Why?
|
| Vinca Alkaloids | 1 | 2005 | 36 | 0.060 |
Why?
|
| Dimerization | 2 | 2007 | 891 | 0.060 |
Why?
|
| Microglia | 1 | 2014 | 1362 | 0.060 |
Why?
|
| Aorta | 2 | 2003 | 2041 | 0.060 |
Why?
|
| Neuroglia | 1 | 2011 | 956 | 0.060 |
Why?
|
| Allopurinol | 1 | 2006 | 198 | 0.060 |
Why?
|
| Sulfoglycosphingolipids | 1 | 2024 | 29 | 0.060 |
Why?
|
| Ventricular Function, Left | 3 | 2011 | 3879 | 0.060 |
Why?
|
| Physical Conditioning, Animal | 1 | 2008 | 365 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2011 | 755 | 0.060 |
Why?
|
| Acetylcysteine | 2 | 2002 | 260 | 0.060 |
Why?
|
| Single-Blind Method | 3 | 2023 | 1574 | 0.060 |
Why?
|
| Middle Aged | 18 | 2024 | 220921 | 0.060 |
Why?
|
| Compliance | 1 | 2024 | 100 | 0.060 |
Why?
|
| Dopamine | 1 | 2011 | 1607 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 2917 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2001 | 7859 | 0.060 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2004 | 32 | 0.060 |
Why?
|
| Respiration, Artificial | 3 | 2023 | 2630 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2010 | 1989 | 0.060 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2004 | 56 | 0.060 |
Why?
|
| Antigens, CD1d | 1 | 2024 | 228 | 0.060 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2002 | 353 | 0.060 |
Why?
|
| Pain | 1 | 1999 | 5073 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 2007 | 2677 | 0.060 |
Why?
|
| Gene Deletion | 2 | 2021 | 2665 | 0.050 |
Why?
|
| Lipids | 1 | 2014 | 3341 | 0.050 |
Why?
|
| Shock, Cardiogenic | 1 | 2009 | 709 | 0.050 |
Why?
|
| Pandemics | 2 | 2020 | 8656 | 0.050 |
Why?
|
| Respiratory Rate | 1 | 2024 | 176 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2020 | 3094 | 0.050 |
Why?
|
| Carboxyhemoglobin | 1 | 2023 | 83 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 6214 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2021 | 11530 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2009 | 1171 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2009 | 4125 | 0.050 |
Why?
|
| Kynurenine | 1 | 2023 | 141 | 0.050 |
Why?
|
| Acetaldehyde | 1 | 2022 | 39 | 0.050 |
Why?
|
| Molecular Structure | 2 | 2019 | 1880 | 0.050 |
Why?
|
| Propylene Glycol | 1 | 2022 | 30 | 0.050 |
Why?
|
| Quinones | 1 | 2022 | 78 | 0.050 |
Why?
|
| Ethylenediamines | 1 | 2002 | 57 | 0.050 |
Why?
|
| Superoxides | 2 | 2017 | 387 | 0.050 |
Why?
|
| Aged | 10 | 2024 | 169310 | 0.050 |
Why?
|
| Indomethacin | 1 | 2002 | 325 | 0.050 |
Why?
|
| Heart Failure | 2 | 2021 | 11671 | 0.050 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 2 | 1999 | 144 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 6075 | 0.050 |
Why?
|
| Aldehydes | 1 | 2022 | 170 | 0.050 |
Why?
|
| Anesthetics, Intravenous | 2 | 2004 | 395 | 0.050 |
Why?
|
| Glycerol | 1 | 2022 | 274 | 0.050 |
Why?
|
| Hospitalization | 1 | 2021 | 10721 | 0.050 |
Why?
|
| Calcitonin Receptor-Like Protein | 1 | 2021 | 13 | 0.050 |
Why?
|
| Random Allocation | 3 | 2016 | 2395 | 0.050 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2024 | 411 | 0.050 |
Why?
|
| Ataxia | 1 | 2023 | 306 | 0.050 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 2001 | 93 | 0.050 |
Why?
|
| Formaldehyde | 1 | 2022 | 358 | 0.050 |
Why?
|
| Anaerobiosis | 1 | 2021 | 138 | 0.050 |
Why?
|
| Infusions, Intravenous | 3 | 2008 | 2217 | 0.050 |
Why?
|
| Fibrosis | 2 | 2008 | 2049 | 0.050 |
Why?
|
| Leukotriene Antagonists | 1 | 2001 | 124 | 0.040 |
Why?
|
| Prospective Studies | 10 | 2021 | 54423 | 0.040 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2024 | 339 | 0.040 |
Why?
|
| Eicosanoids | 1 | 2002 | 282 | 0.040 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2002 | 361 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2024 | 730 | 0.040 |
Why?
|
| Sarcomeres | 2 | 2014 | 368 | 0.040 |
Why?
|
| Intubation, Intratracheal | 2 | 1998 | 1333 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 2014 | 3233 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2004 | 1494 | 0.040 |
Why?
|
| Base Sequence | 1 | 2011 | 12441 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2005 | 1113 | 0.040 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2019 | 21 | 0.040 |
Why?
|
| Infant, Newborn | 4 | 2007 | 26202 | 0.040 |
Why?
|
| Iron Regulatory Protein 2 | 1 | 2019 | 42 | 0.040 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2019 | 49 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2002 | 849 | 0.040 |
Why?
|
| Organometallic Compounds | 1 | 2002 | 647 | 0.040 |
Why?
|
| Methylene Blue | 1 | 2019 | 155 | 0.040 |
Why?
|
| Alcohol Oxidoreductases | 1 | 1999 | 169 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2011 | 1334 | 0.040 |
Why?
|
| Pyruvic Acid | 1 | 2020 | 204 | 0.040 |
Why?
|
| Progesterone | 1 | 2023 | 742 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2019 | 84 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 23996 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2019 | 193 | 0.040 |
Why?
|
| American Heart Association | 1 | 2023 | 1039 | 0.040 |
Why?
|
| Vecuronium Bromide | 1 | 1998 | 33 | 0.040 |
Why?
|
| Sulfones | 1 | 2001 | 448 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2001 | 652 | 0.040 |
Why?
|
| Nicotine | 1 | 2023 | 680 | 0.040 |
Why?
|
| Adenosine Diphosphate | 1 | 2019 | 422 | 0.040 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2021 | 323 | 0.040 |
Why?
|
| Nitroprusside | 2 | 1998 | 272 | 0.040 |
Why?
|
| 5'-Nucleotidase | 1 | 2019 | 161 | 0.040 |
Why?
|
| Fourier Analysis | 1 | 1999 | 441 | 0.040 |
Why?
|
| Pyrazoles | 2 | 2008 | 2009 | 0.040 |
Why?
|
| Thermodilution | 1 | 2018 | 50 | 0.040 |
Why?
|
| Psychomotor Agitation | 1 | 2000 | 305 | 0.040 |
Why?
|
| Heart Function Tests | 2 | 2011 | 318 | 0.040 |
Why?
|
| Adenosine Monophosphate | 1 | 2019 | 231 | 0.040 |
Why?
|
| Rheology | 1 | 1999 | 347 | 0.040 |
Why?
|
| Purines | 1 | 2001 | 607 | 0.040 |
Why?
|
| Laryngeal Masks | 1 | 1998 | 103 | 0.040 |
Why?
|
| Reflex, Righting | 1 | 2017 | 19 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 36426 | 0.040 |
Why?
|
| Tyrosine | 1 | 2002 | 1440 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2008 | 2639 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 2 | 1998 | 654 | 0.040 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 1998 | 143 | 0.040 |
Why?
|
| Forecasting | 2 | 2004 | 2928 | 0.040 |
Why?
|
| Anesthesia, Inhalation | 1 | 1998 | 220 | 0.040 |
Why?
|
| Triazines | 1 | 2019 | 311 | 0.040 |
Why?
|
| Models, Biological | 1 | 2013 | 9469 | 0.030 |
Why?
|
| RNA, Messenger | 5 | 2016 | 12794 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 619 | 0.030 |
Why?
|
| Neuromuscular Blockade | 1 | 1998 | 147 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2008 | 2882 | 0.030 |
Why?
|
| Myocardial Infarction | 2 | 2010 | 11461 | 0.030 |
Why?
|
| Cell Count | 1 | 2021 | 1835 | 0.030 |
Why?
|
| Apyrase | 1 | 2019 | 373 | 0.030 |
Why?
|
| Pyridines | 2 | 2008 | 2875 | 0.030 |
Why?
|
| Glioma | 1 | 2011 | 3455 | 0.030 |
Why?
|
| P-Selectin | 1 | 1999 | 597 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2020 | 3733 | 0.030 |
Why?
|
| Prodrugs | 1 | 1998 | 261 | 0.030 |
Why?
|
| Estradiol | 1 | 2023 | 1937 | 0.030 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1999 | 545 | 0.030 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 1 | 1995 | 58 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2004 | 1086 | 0.030 |
Why?
|
| Polymers | 1 | 2022 | 1616 | 0.030 |
Why?
|
| Cyclization | 1 | 2015 | 59 | 0.030 |
Why?
|
| Thromboxane A2 | 1 | 1995 | 88 | 0.030 |
Why?
|
| Postoperative Hemorrhage | 1 | 1999 | 415 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 2016 | 427 | 0.030 |
Why?
|
| Free Radicals | 1 | 2015 | 238 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 1999 | 673 | 0.030 |
Why?
|
| Anesthesia, Epidural | 1 | 1997 | 233 | 0.030 |
Why?
|
| Ventricular Function | 1 | 1996 | 406 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2014 | 2748 | 0.030 |
Why?
|
| Endothelium | 1 | 1997 | 765 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2019 | 823 | 0.030 |
Why?
|
| Adult | 11 | 2024 | 221210 | 0.030 |
Why?
|
| Blood Proteins | 1 | 1999 | 1173 | 0.030 |
Why?
|
| Breath Tests | 2 | 2011 | 299 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 2024 | 1667 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 2201 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2019 | 22176 | 0.030 |
Why?
|
| Heart Ventricles | 2 | 2021 | 3807 | 0.030 |
Why?
|
| Calcium Signaling | 2 | 2011 | 733 | 0.030 |
Why?
|
| Triazoles | 1 | 2019 | 903 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 3076 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2014 | 826 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 1 | 2015 | 301 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 1136 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 1998 | 1201 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 976 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 74213 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2023 | 2400 | 0.030 |
Why?
|
| Electromyography | 1 | 1998 | 1394 | 0.030 |
Why?
|
| COS Cells | 1 | 2014 | 1130 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2002 | 3687 | 0.030 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2011 | 63 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2014 | 931 | 0.020 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 2011 | 93 | 0.020 |
Why?
|
| Heparin | 1 | 1999 | 1634 | 0.020 |
Why?
|
| Stroke Volume | 2 | 2021 | 5496 | 0.020 |
Why?
|
| Chemokine CXCL2 | 1 | 2011 | 106 | 0.020 |
Why?
|
| Acetylation | 1 | 2014 | 1055 | 0.020 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 15843 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1998 | 2048 | 0.020 |
Why?
|
| Adrenergic beta-3 Receptor Agonists | 1 | 2011 | 14 | 0.020 |
Why?
|
| Protein Prenylation | 1 | 2011 | 70 | 0.020 |
Why?
|
| Receptor, Muscarinic M2 | 1 | 2011 | 15 | 0.020 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2011 | 28 | 0.020 |
Why?
|
| Metabolomics | 1 | 2021 | 1659 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2011 | 52 | 0.020 |
Why?
|
| Spermine | 1 | 2011 | 70 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2011 | 62 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2023 | 3575 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2021 | 2856 | 0.020 |
Why?
|
| Acetylcholine | 2 | 2007 | 629 | 0.020 |
Why?
|
| Hypokinesia | 1 | 2010 | 23 | 0.020 |
Why?
|
| Infant | 3 | 2004 | 36193 | 0.020 |
Why?
|
| Cytotoxins | 1 | 2011 | 153 | 0.020 |
Why?
|
| Ethanolamines | 1 | 2011 | 153 | 0.020 |
Why?
|
| Iron | 1 | 2019 | 1793 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 613 | 0.020 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2010 | 122 | 0.020 |
Why?
|
| Neutrophil Activation | 1 | 2011 | 180 | 0.020 |
Why?
|
| HMGB1 Protein | 1 | 2011 | 137 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2011 | 215 | 0.020 |
Why?
|
| Cell Line | 2 | 2016 | 15601 | 0.020 |
Why?
|
| Leukotriene B4 | 1 | 2011 | 280 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2019 | 1456 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4281 | 0.020 |
Why?
|
| Models, Animal | 2 | 2007 | 2112 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2011 | 1302 | 0.020 |
Why?
|
| Pregnancy | 2 | 2022 | 29890 | 0.020 |
Why?
|
| Neurotoxins | 1 | 2010 | 240 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2011 | 565 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2010 | 370 | 0.020 |
Why?
|
| Aging | 1 | 2008 | 8710 | 0.020 |
Why?
|
| Wakefulness | 2 | 2008 | 1265 | 0.020 |
Why?
|
| Tidal Volume | 1 | 2011 | 488 | 0.020 |
Why?
|
| Ketamine | 1 | 1995 | 519 | 0.020 |
Why?
|
| Metabolome | 1 | 2016 | 989 | 0.020 |
Why?
|
| Locomotion | 1 | 2011 | 388 | 0.020 |
Why?
|
| Substantia Nigra | 1 | 2010 | 350 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2019 | 4001 | 0.020 |
Why?
|
| Sodium Nitrite | 1 | 2008 | 16 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 29629 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2009 | 210 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1999 | 5870 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2019 | 2688 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2014 | 5971 | 0.020 |
Why?
|
| Methemoglobinemia | 1 | 2008 | 44 | 0.020 |
Why?
|
| Critical Illness | 1 | 2021 | 2723 | 0.020 |
Why?
|
| Neutrophils | 2 | 2011 | 3767 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 8633 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 1541 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2024 | 41495 | 0.020 |
Why?
|
| Genotype | 1 | 2002 | 12990 | 0.020 |
Why?
|
| Ethers | 2 | 1997 | 73 | 0.020 |
Why?
|
| Premedication | 1 | 2008 | 246 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2014 | 13446 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 311 | 0.020 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2007 | 108 | 0.020 |
Why?
|
| Antimetabolites | 1 | 2007 | 129 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 10090 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 3847 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 17635 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1862 | 0.020 |
Why?
|
| Liver Diseases | 1 | 2014 | 1297 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 1996 | 2113 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2008 | 463 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2007 | 342 | 0.020 |
Why?
|
| Dipeptides | 1 | 2007 | 391 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2008 | 614 | 0.020 |
Why?
|
| Swine | 1 | 2015 | 5915 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2011 | 1241 | 0.020 |
Why?
|
| Spleen | 1 | 2011 | 2295 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 14608 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2007 | 390 | 0.020 |
Why?
|
| Guanylate Cyclase-Activating Proteins | 1 | 2004 | 3 | 0.020 |
Why?
|
| United States | 2 | 2023 | 72340 | 0.020 |
Why?
|
| Dobutamine | 1 | 2005 | 116 | 0.020 |
Why?
|
| Propanolamines | 1 | 2005 | 163 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3415 | 0.010 |
Why?
|
| Contrast Media | 1 | 2018 | 5307 | 0.010 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2004 | 86 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9280 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2010 | 1509 | 0.010 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2004 | 72 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 10212 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2011 | 1403 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4576 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2011 | 6131 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 2014 | 2091 | 0.010 |
Why?
|
| Anticoagulants | 1 | 1999 | 4812 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3810 | 0.010 |
Why?
|
| Arterioles | 1 | 2004 | 250 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10451 | 0.010 |
Why?
|
| Hippocampus | 1 | 2016 | 3766 | 0.010 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2007 | 326 | 0.010 |
Why?
|
| Midazolam | 1 | 2004 | 266 | 0.010 |
Why?
|
| Lysine | 1 | 2007 | 993 | 0.010 |
Why?
|
| Lipoproteins | 1 | 2007 | 881 | 0.010 |
Why?
|
| Thoracotomy | 1 | 2004 | 367 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 7879 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2006 | 678 | 0.010 |
Why?
|
| Macrophages | 1 | 2017 | 5767 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 7406 | 0.010 |
Why?
|
| Age Factors | 1 | 1999 | 18399 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2011 | 6345 | 0.010 |
Why?
|
| Fentanyl | 1 | 2004 | 434 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2008 | 1301 | 0.010 |
Why?
|
| Preanesthetic Medication | 1 | 2000 | 48 | 0.010 |
Why?
|
| Enzyme Stability | 1 | 2001 | 219 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 58984 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9420 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2004 | 1416 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 5779 | 0.010 |
Why?
|
| Aldehyde Reductase | 1 | 1999 | 71 | 0.010 |
Why?
|
| Absorption | 1 | 1999 | 242 | 0.010 |
Why?
|
| Polypropylenes | 1 | 1999 | 63 | 0.010 |
Why?
|
| Leukocytes | 1 | 2007 | 2026 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2000 | 42232 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2008 | 2413 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1999 | 240 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2022 | 80647 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6484 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1999 | 750 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2004 | 15502 | 0.010 |
Why?
|
| Exons | 1 | 2004 | 2391 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2011 | 3839 | 0.010 |
Why?
|
| Movement | 1 | 2005 | 1478 | 0.010 |
Why?
|
| Cell Movement | 1 | 2010 | 5205 | 0.010 |
Why?
|
| Boston | 1 | 2011 | 9327 | 0.010 |
Why?
|
| Nitrogen Oxides | 1 | 1998 | 129 | 0.010 |
Why?
|
| Catalysis | 1 | 1999 | 774 | 0.010 |
Why?
|
| Membranes, Artificial | 1 | 1999 | 366 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 6374 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11076 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2001 | 943 | 0.010 |
Why?
|
| Acceleration | 1 | 1998 | 189 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2001 | 1248 | 0.010 |
Why?
|
| Testosterone | 1 | 2008 | 2472 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 1741 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1999 | 1762 | 0.010 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 1999 | 577 | 0.010 |
Why?
|
| Young Adult | 1 | 2023 | 59260 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1999 | 1704 | 0.010 |
Why?
|
| Hydrazines | 1 | 1998 | 224 | 0.010 |
Why?
|
| Weight Loss | 1 | 2007 | 2684 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1999 | 1496 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1999 | 1791 | 0.010 |
Why?
|
| Adolescent | 1 | 2023 | 88326 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2000 | 2079 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1997 | 838 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 10194 | 0.010 |
Why?
|
| Thorax | 1 | 1997 | 555 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 4772 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1994 | 367 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2007 | 9319 | 0.010 |
Why?
|
| Consciousness | 1 | 1997 | 601 | 0.010 |
Why?
|
| Child | 1 | 1999 | 80158 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2004 | 12341 | 0.010 |
Why?
|
| Mitral Valve | 1 | 1997 | 1465 | 0.000 |
Why?
|
| Data Interpretation, Statistical | 1 | 1997 | 2691 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1999 | 4217 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1997 | 6312 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 7593 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 20100 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1999 | 9177 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1997 | 9001 | 0.000 |
Why?
|